Michael M Tarnow Xenon Pharmaceuticals Inc. (XENE) insider trading activity

XENE Quotes by TradingView

Michael M Tarnow is Director of Xenon Pharmaceuticals Inc.. Currently has a direct ownership of 77,942 shares of XENE, which is worth approximately $3.25 Million. The most recent transaction as insider was on May 18, 2021, when has been sold 8,229 shares (Common Shares) at a price of $3.74 per share, resulting in proceeds of $30,776. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.9K
0% 3M change
0% 12M change
Total Value Held $3.25 Million

MICHAEL M TARNOW Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2021
BUY
Exercise of conversion of derivative security
$30,776 $3.74 p/Share
8,229 Added 9.55%
77,942 Common Shares
Oct 28 2020
SELL
Bona fide gift
-
10,288 Reduced 12.86%
69,713 Common Shares
Oct 28 2020
BUY
Exercise of conversion of derivative security
$38,683 $3.76 p/Share
10,288 Added 11.39%
80,001 Common Shares
MMT

Michael M Tarnow

Director
Burnaby, A1

Track Institutional and Insider Activities on XENE

Follow Xenon Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XENE shares.

Notify only if

Insider Trading

Get notified when an Xenon Pharmaceuticals Inc. insider buys or sells XENE shares.

Notify only if

News

Receive news related to Xenon Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XENE